| 1 | FGF10, FGF3
|
| Direct and indirect roles of Fgf3 and Fgf10 in innervation and vascularisation of the vertebrate hypothalamic neurohypophysis.
|
| Liu F, Pogoda HM, Pearson CA, Ohyama K, Lhr H, Hammerschmidt M, Placzek M.
|
| Development 140(5):1111-22. doi: 10.1242/dev.080226.
2013
|
| 2 | FGF10, FGF3
|
| Redundant and dosage sensitive requirements for Fgf3 and Fgf10 in cardiovascular development.
|
| Urness LD, Bleyl SB, Wright TJ, Moon AM, Mansour SL.
|
| Dev Biol 356(2):383-97. Epub 2011 Jun 12.
2011
|
| 3 | CDMM, FGF3
|
| LAMM syndrome with middle ear dysplasia associated with compound heterozygosity for FGF3 mutations.
|
| Sensi A, Ceruti S, Trevisi P, Gualandi F, Busi M, Donati I, Neri M, Ferlini A, Martini A.
|
| Am J Med Genet A 155A(5):1096-101. doi: 10.1002/ajmg.a.33962. Epub 2011 Apr 7.
2011
|
| 4 | CDMM, FGF3
|
| Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome.
|
| Riazuddin S, Ahmed ZM, Hegde RS, Khan SN, Nasir I, Shaukat U, Riazuddin S, Butman JA, Griffith AJ, Friedman TB, Choi BY.
|
| BMC Med Genet 12:21.
2011
|
| 5 | FGF10, FGF3, WNT8A
|
| FGF signaling regulates otic placode induction and refinement by controlling both ectodermal target genes and hindbrain Wnt8a.
|
| Urness LD, Paxton CN, Wang X, Schoenwolf GC, Mansour SL.
|
| Dev Biol 340(2):595-604. Epub 2010 Feb 18.
2010
|
| 6 | CDMM, FGF3, OTDD
|
| A FGF3 mutation associated with differential inner ear malformation, microtia, and microdontia.
|
| Ramsebner R, Ludwig M, Parzefall T, Lucas T, Baumgartner WD, Bodamer O, Cengiz FB, Schoefer C, Tekin M, Frei K.
|
| Laryngoscope 120(2):359-64.
2010
|
| 7 | FGF3, OTDD
|
| Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3).
|
| Alsmadi O, Meyer BF, Alkuraya F, Wakil S, Alkayal F, Al-Saud H, Ramzan K, Al-Sayed M.
|
| Eur J Hum Genet 17(1):14-21. Epub 2008 Aug 13.
2009
|
| 8 | FGF3
|
| FGF signaling controls caudal hindbrain specification through Ras-ERK1/2 pathway.
|
| Aragon F, Pujades C.
|
| BMC Dev Biol 9:61.
2009
|
| 9 | FGF3, OTDD
|
| Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia.
|
| Tekin M, Oztrkmen Akay H, Fitoz S, Birnbaum S, Cengiz FB, Sennarolu L, Incesulu A, Yksel Konuk EB, Hasanefendiolu Bayrak A, Sentrk S, Cebeci I, Utine GE, Tunbilek E, Nance WE, Duman D.
|
| Clin Genet 73(6):554-65. Epub 2008 Apr 22. 2008
|
| 10 | FGF3, CDMM
|
| Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia.
|
| Tekin M, Hismi BO, Fitoz S, Ozdag H, Cengiz FB, Sirmaci A, Aslan I, Inceoglu B, Yuksel-Konuk EB, Yilmaz ST, Yasun O, Akar N.
|
| Am J Hum Genet 80(2):338-44. Epub 2006 Dec 27. 2007
|
| 11 | DUP11QP, FGF3, FGF4
|
| An 11q11-q13.3 duplication, including FGF3 and FGF4 genes, in a patient with syndromic multiple craniosynostoses.
|
| Jehee FS, Bertola DR, Yelavarthi KK, Krepischi-Santos AC, Kim C, Vianna-Morgante AM, Vermeesch JR, Passos-Bueno MR.
|
| Am J Med Genet A 143(16):1912-8. 2007
|
| 12 | FGF3
|
| Impaired FGF signaling contributes to cleft lip and palate.
|
| Riley BM, Mansilla MA, Ma J, Daack-Hirsch S, Maher BS, Raffensperger LM, Russo ET, Vieira AR, Dode C, Mohammadi M, Marazita ML, Murray JC.
|
| Proc Natl Acad Sci U S A 104(11):4512-7. Epub 2007 Mar 6. 2007
|
| 13 | ANO1, C11orf78, FADD, FGF3
|
| SNP genome scanning localizes oto-dental syndrome to chromosome 11q13 and microdeletions at this locus implicate FGF3 in dental and inner-ear disease and FADD in ocular coloboma.
|
| Gregory-Evans CY, Moosajee M, Hodges MD, Mackay DS, Game L, Vargesson N, Bloch-Zupan A, Ruschendorf F, Santos-Pinto L, Wackens G, Gregory-Evans K.
|
| Hum Mol Genet 16(20):3482-93. Epub 2007 Jul 25. 2007
|
| 14 | FGF3
|
| Fgf3 is required for dorsal patterning and morphogenesis of the inner ear epithelium.
|
| Hatch EP, Noyes CA, Wang X, Wright TJ, Mansour SL.
|
| Development 134(20):3615-25. Epub 2007 Sep 12.
2007
|
| 15 | CCND1, ORAOV1, CTTN, SHANK2, FGF3
|
| Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.
|
| Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P, Joos S.
|
| Genes Chromosomes Cancer 45(2):118-25. 2006
|
| 16 | FGF3
|
| Fibroblast growth factor 3, a protein with a dual subcellular fate, is interacting with human ribosomal protein S2.
|
| Antoine M, Reimers K, Wirz W, Gressner AM, Muller R, Kiefer P.
|
| Biochem Biophys Res Commun 338(2):1248-55. Epub 2005 Oct 24. 2005
|
| 17 | FGF1, FGF2, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF20, FGF21, FGF22, FGF23
|
| Evolution of the Fgf and Fgfr gene families.
|
| Itoh N, Ornitz DM.
|
| Trends Genet 20(11):563-9. 2004
|
| 18 | FGF3
|
| Minimal expression of the proto-oncogene int-2 encoded protein in a series of colorectal carcinomas.
|
| Papanikolaou IS, Lazaris AC, Kavantzas N, Davaris PS.
|
| J Gastroenterol Hepatol 17(10):1084-6. 2002
|
| 19 | CRSCNS, FGF3
|
| A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) causes non-syndromic craniosynostosis.
|
| Tsai FJ, Wu JY, Lee CC, Tsa CH.
|
| Acta Paediatr 89(6):672-4. 2000
|
| 20 | CCND1, CTTN, FGF3
|
| EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
|
| Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R, Sutherland RL.
|
| Oncogene 15(13):1617-23. 1997
|
| 21 | ACAT1, ATM, CRYAB, FDX1, FGF3, GRIA4, NCAM1, D11S1818, D11S1897, D11S1960, D11S2
|
| Generation of a panel of radiation-reduced hybrids containing human 11q22-23 fragments bearing a HPRT selective marker : identification of hybrids carrying various subregions around the ataxia-telangiectasia locus.
|
| Ejima Y, et al.
|
| Somat Cell Mol Genet 22 : 499-509. 1996
|
| 22 | FGF3
|
| Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas.
|
| Meyers SL, et al.
|
| Mol Carcinog 6 : 243-251. 1992
|
| 23 | FGF3
|
| Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2).
|
| Polymeropoulos MH, et al.
|
| Nucleic Acids Res 18 : 7468. 1990
|
| 24 | FGF3, MEN1
|
| Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
|
| Thakker RV, et al.
|
| N Engl J Med 321 : 218-224. 1989
|
| 25 | FGF3, FGF4, FGF3, BCL1
|
| The FGF-related oncogenes hst and int2, and the bcl.1 locus are contained within one megabase in band q13 of chromosome 11, while the fgf.5 oncogene maps to 4q21.
|
| Nguyen C, et al.
|
| Oncogene 3 : 703-708. 1988
|
| 26 | FGF3
|
| Genetic linkage studies in multiple endocrine neoplasia type 1 (MEN1).
|
| Bale SJ, et al.
|
| Am J Hum Genet 43 : A19. 1988
|
| 27 | EGFR, FGF3
|
| Polymorphisms of EGFR and INT2, candidate loci for human breast cancer.
|
| Hall J, et al.
|
| (HGM9) Cytogenet Cell Genet 46 : 625. 1987
|
| 28 | FGF3
|
| Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene.
|
| Casey G, et al.
|
| Mol Cell Biol 6 : 502-510. 1986
|